Biotechnology · Health Care
Astrivax: Products & infrastructure
Data updated Nov 21, 2026 · Back to the company report
Products
2EU trials (CTIS)
EU clinical trialsthe trials it sponsors, per the EU's CTIS register
A study to assess the safety and immunogenicity of a therapeutic hepatitis B virus vaccine, in healthy adults (RUBY).
Human Pharmacology (Phase I)- First administration to humans · Hepatitis B · Belgium
Apr 2025
A Phase I, randomized, double-blind, multi-centre, placebo-controlled, dose-escalation study to evaluate the safety, re…
Human Pharmacology (Phase I)- First administration to humans · Yellow fever, Rabies · Belgium
Jun 2024
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
